Live Breaking News & Updates on Regenerative Medicine Action Awards

Stay updated with breaking news from Regenerative medicine action awards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows


 E-Mail
IMAGE: Research team from Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam.
view more 
Credit: AlphaMed Press
Durham, NC Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in
STEM CELLS Translational Medicine.
In a randomized clinical trial at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, researchers investigated the safety and potential therapeutic value of administering bone marrow stromal stem cells to patients with Type 2 diabetes. In each case, the cells were autologous, or taken from the patients own bodies. ....

Republic Of , Han I , United Kingdom , Northern Ireland , San Francisco , United States , Anthony Atala , Liem Nguyen , Regenerative Medicine Foundation , Wake Forest Institute For Regenerative Medicine , Vinmec Research Institute Of Stem Cell , Gene Technology , Vinmec Research Institute , Stem Cell , Wake Forest Institute , Mellitus Duration , Obesity Alter , Stromal Cells , Alphamed Press , Regenerative Medicine , World Stem Cell Summit , Regenerative Medicine Action Awards , Cell Biology , Clinical Trials , குடியரசு ஆஃப் , ஹான் நான் ,

Clinical trial assesses stem cells' ability to prevent major cause of preemie deaths


Credit: AlphaMed Press
Durham, NC - A phase 2 clinical trial whose results were released today in
STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung Medical Center, Sungkyunkwan University and Asan Medical Center Children s Hospital in Seoul, evaluates the effectiveness of treating these infants by transplanting umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas.
Early results showed signs of improvement for the most immature infants included in the trial.
BPD is a serious breathing disorder in which the lungs do not develop normally. Most infants who develop BPD are born more than 10 weeks before their due date, weigh less than 2 pounds at birth, and have breathing problems. Infections that occur before or shortly after birth also can contribute to the disorder. Despite recent advance ....

Soult Ukpyolsi , South Korea , United Kingdom , Northern Ireland , San Francisco , United States , Anthony Atala , Regenerative Medicine Foundation , Asan Medical Center Children Hospital , Sungkyunkwan University , University Of Ulsan , Samsung Medical Center , Sungkyunkwan University School Of Medicine , Wake Forest Institute For Regenerative Medicine , Asan Medical Center Children , Soon Park , Sungkyunkwan University School , Ellen Ai Rhan Kim , Wake Forest Institute , Alphamed Press , Regenerative Medicine , World Stem Cell Summit , Stem Cell , Regenerative Medicine Action Awards , தெற்கு கொரியா , ஒன்றுபட்டது கிஂக்டம் ,